首页 › 基金 › BAKER BROS. ADVISORS LP › SMMT
BAKER BROS. ADVISORS LP 对 SMMT 的持仓历史
SUMMIT THERAPEUTICS INC · 医疗保健
BAKER BROS. ADVISORS LP 在 Q3 2026 的 13F 申报中披露持有 SMMT(SUMMIT THERAPEUTICS INC)32,786,348 股,市值约 US$554.4M,约占其申报组合的 2.68%,在其申报持仓中市值排名第 10 位。 BAKER BROS. ADVISORS LP 最近 13 个申报季度中有 11 个季度披露了 SMMT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
BAKER BROS. ADVISORS LP 对 SMMT 的持仓演变
BAKER BROS. ADVISORS LP 于 Q3 2023 首次披露 SMMT 持仓:3,140,473 股(约 US$5.9M)。 该持仓在 Q2 2025 达到峰值 33,722,974 股,市值约 US$717.6M。 在 11 次申报中,BAKER BROS. ADVISORS LP 3 次增持、1 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 32,786,348 股、市值约 US$554.4M。 持仓曾出现大幅变动:Q2 2025 增持约 38% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 3.14M | $5.87M | 新进 |
| Q2 2024 | 23.22M | $181.13M | 新进 |
| Q3 2024 | 24.42M | $534.90M | 增持 |
| Q4 2024 | 24.42M | $435.86M | 持有 |
| Q1 2025 | 24.42M | $471.16M | 持有 |
| Q2 2025 | 33.72M | $717.62M | 增持 |
| Q3 2025 | 33.72M | $696.72M | 持有 |
| Q4 2025 | 36.39M | $636.48M | 增持 |
| Q1 2026 | 36.39M | $689.97M | 持有 |
| Q2 2026 | 32.79M | $477.70M | 减持 |
| Q3 2026 | 32.79M | $554.42M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SMMT 与 13F 数据
SMMT(SUMMIT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 SMMT,申报仓位最大的包括:Kynam Capital Management, LP (US$50.7M), Bellevue Group AG (US$35.7M), Affinity Asset Advisors, LLC (US$28.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SMMT 的基金
- Kynam Capital Management, LP 3.00M 股 · $50.73M · Q3 2026
- Bellevue Group AG 2.11M 股 · $35.74M · Q3 2026
- Affinity Asset Advisors, LLC 1.70M 股 · $28.75M · Q3 2026
- Logos Global Management LP 1.00M 股 · $16.91M · Q3 2026
- GMT CAPITAL CORP 760.80K 股 · $12.87M · Q3 2026
- Rock Springs Capital Management LP 715.00K 股 · $12.09M · Q3 2026
- Ikarian Capital, LLC 650.00K 股 · $10.99M · Q3 2026
- Eversept Partners, LP 526.65K 股 · $8.91M · Q3 2026
- Simplify Asset Management Inc. 510.11K 股 · $8.63M · Q3 2026
- First Turn Management, LLC 501.72K 股 · $8.48M · Q3 2026
- Elmind Capital, LP 493.82K 股 · $8.35M · Q3 2026
- HOHIMER WEALTH MANAGEMENT, LLC 441.65K 股 · $7.47M · Q3 2026
更多关于 BAKER BROS. ADVISORS LP
常见问题
How long has BAKER BROS. ADVISORS LP held SMMT?
BAKER BROS. ADVISORS LP has disclosed SMMT holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in SMMT?
As of Q3 2026, BAKER BROS. ADVISORS LP holds 32.79M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $554.42M, representing 2.68% of its reported portfolio and ranking #10.
Has BAKER BROS. ADVISORS LP been buying or selling SMMT?
In the latest 13F filing (Q3 2026), BAKER BROS. ADVISORS LP held unchanged its position in SMMT. The position peaked in Q2 2025 at 33.72M shares.
Which other funds hold SMMT?
Other major institutional holders of SMMT include Kynam Capital Management, LP, Bellevue Group AG, Affinity Asset Advisors, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.